CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,585,993
-62.3%
94,269
-9.8%
0.01%
-53.8%
Q2 2023$9,518,766
+28.2%
104,487
-7.2%
0.01%
+18.2%
Q1 2023$7,427,294
+26.1%
112,603
-1.1%
0.01%
+22.2%
Q4 2022$5,890,234
-21.9%
113,909
+3.2%
0.01%
-30.8%
Q3 2022$7,538,000
+57.8%
110,360
+4.5%
0.01%
+62.5%
Q2 2022$4,776,000
-5.0%
105,614
+6.8%
0.01%
+14.3%
Q1 2022$5,027,000
+2.5%
98,930
-4.6%
0.01%
+16.7%
Q4 2021$4,903,000
+75.8%
103,701
+22.6%
0.01%
+50.0%
Q3 2021$2,789,000
-50.7%
84,617
-5.5%
0.00%
-42.9%
Q2 2021$5,658,000
+45.6%
89,522
-1.1%
0.01%
+40.0%
Q1 2021$3,886,000
-25.2%
90,557
-0.3%
0.01%
-28.6%
Q4 2020$5,195,000
+89.4%
90,830
-0.1%
0.01%
+75.0%
Q3 2020$2,743,000
-7.2%
90,923
+0.4%
0.00%
-20.0%
Q2 2020$2,957,000
+26.9%
90,546
+4.1%
0.01%0.0%
Q1 2020$2,330,000
+2.0%
86,974
+16.6%
0.01%
+25.0%
Q4 2019$2,284,000
+25.8%
74,591
-1.0%
0.00%0.0%
Q3 2019$1,815,000
-3.8%
75,326
+1.2%
0.00%0.0%
Q2 2019$1,886,000
+75.0%
74,417
+34.6%
0.00%
+100.0%
Q1 2019$1,078,000
+44.3%
55,297
-2.4%
0.00%0.0%
Q4 2018$747,000
-24.0%
56,645
+2.5%
0.00%0.0%
Q3 2018$983,000
-19.2%
55,268
-0.0%
0.00%
-33.3%
Q2 2018$1,216,000
+228.6%
55,271
+230.4%
0.00%
+200.0%
Q1 2018$370,0000.0%16,727
-2.0%
0.00%0.0%
Q4 2017$370,00017,0660.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders